Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Results of the GENUINE Phase 3 study

Drug Category : Array
Conference Category : Array
Lead Author : Mato A, et al.
Published Date : 16/06/2017
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/Final%20GENUINE%20ICML%202017%20Mato.PDF
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top